On September 10, 2020 Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, reported it will participate in five upcoming investor conferences (Press release, Novavax, SEP 10, 2020, View Source [SID1234564955]). A topic of discussion will be Novavax’ COVID-19 vaccine candidate, NVX-CoV2373.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference details are as follows:
Citi 15th Annual BioPharma Virtual Conference
Date: September 10, 2020
Event: Investor meetings only
H.C. Wainwright 22nd Annual Global Investment Conference
Date: September 14, 2020
Time: 9:30 a.m. U.S. Eastern Time (ET)
Event: Corporate presentation and investor meetings
Live Webcast: www.novavax.com, "Investors"/ "Events"
Cantor Virtual Global Healthcare Conference
Date: September 15, 2020
Time: 11:20 a.m. U.S. Eastern Time (ET)
Event: Fireside chat and investor meetings
Live Webcast: www.novavax.com, "Investors"/ "Events"
Morgan Stanley Virtual 18th Annual Global Healthcare Conference
Date: September 16, 2020
Time: 12:30 p.m. U.S. Eastern Time (ET)
Event: Fireside chat and investor meetings
Live Webcast: www.novavax.com, "Investors"/ "Events"
Leerink CyberRx Series: Vaccine Forum
Date: September 23, 2020
Time: 9:00 a.m. U.S. Eastern Time (ET)
Event: Fireside chat
A replay of the presentations will also be accessible under the "Investors/Events" section www.novavax.com.